King® Guide to Parenteral Admixtures®

Online Edition

Welcome to the King Guide to Parenteral Admixtures Internet Edition.

Enter Login Information



License Agreement


Summer 2026

We included new stability information to the monographs for: CEFTOBIPROLE MEDOCARIL SODIUM, CEFTAZIDIME, CEFTAZIDIME AND AVIBACTAM SODIUM, ERTAPENEM, MEROPENEM, NALBUPHINE HYDROCHLORIDE, and ORPHENADRINE CITRATE.

Compatibility information was added to the monographs for ACYCLOVIR SODIUM, AMIKACIN SULFATE, AMOXICILLIN SODIUM, AMPHOTERICIN B, CEFOTAXIME SODIUM, CEFTRIAXONE SODIUM, CLONAZEPAM, DIAZEPAM, DOBUTAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE, FUROSEMIDE, KETAMINE HYDROCHLORIDE, KETOPROFEN, KETOROLAC, METHADONE HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE, MORPHINE HYDROCHLORIDE, NALBUPHINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, PANTOPRAZOLE SODIUM, SODIUM BICARBONATE, TRAMADOL HYDROCHLORIDE, and VANCOMYCIN HYDROCHLORIDE.

  © 2026 - King Guide Publications, Inc. All rights reserved.